Copyright
©2014 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Apr 16, 2014; 6(4): 121-127
Published online Apr 16, 2014. doi: 10.4253/wjge.v6.i4.121
Published online Apr 16, 2014. doi: 10.4253/wjge.v6.i4.121
Contrast agent | Composition | Manufacturer |
First generation | ||
Albunex | 5% Sonicated serum albumin with stabilized microbubbles | Mallinckrodt |
Echovist (SHU 454) | Standardized microbubbles with galactose shell | Schering |
Levovist (SHU 508) | Stabilized, standardized microbubbles with galactose, 0.1% palmitic acid shell | Schering |
Myomap | Albumin shell | Quadrant |
Qantison | Albumin shell | Quadrant |
Sonavist | Cyanoacrylate shell | Schering |
Second generation | ||
Definity/luminity | C3F8 with lipid stabilizer shell | Bristol-Myers Squibb Medical Imaging |
Sonazoid | C4F10 with lipid stabilizer shell | GE Healthcare |
Imagent-Imavist | C6F14 with lipid stabilizer shell | Alliance |
Optison | C3F8 with denatured human albumin shell | GE Healthcare |
Bisphere/cardiosphere | Polylactide-coglycolide shell with albumin overcoat | Commercially unavailable |
SonoVue | SF6 gas with lipid stabilizer shell | Bracco |
AI700/imagify | C4F10 gas core stabilized with polymer shell | Acusphere |
Third generation | ||
Echogen | Dodecafluoropentane (DDFP) liquid in phase shift colloid emulsion | Sonus Pharmaceuticals |
- Citation: Yip HC, Teoh AYB, Chong CCN, Lau JYW. Current status and future applications of contrast-enhanced endoscopic ultrasonography. World J Gastrointest Endosc 2014; 6(4): 121-127
- URL: https://www.wjgnet.com/1948-5190/full/v6/i4/121.htm
- DOI: https://dx.doi.org/10.4253/wjge.v6.i4.121